BRIEF-EMA recommends suspension of marketing authorisation of Tredaptive in EU

LONDON Fri Jan 11, 2013 7:45am EST

Related News

LONDON, Jan 11 (Reuters) * Ema assessed data related to safety concerns over tredaptive, pelzont and

trevaclyn * Ema -recommended that the marketing, supply and authorisations of these

medicines be suspended across the European union (EU).

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.